Drugs / J4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06938763 | Feb 2025 → Dec 2026 expected | Alzheimer disease | Academia Sinica, Taiwan | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | J4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06938763 ↗ |
| Route | Oral | “after Oral Administration” NCT06938763 ↗ |